Advertisement
DRIO vs IRIX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRIO is a StrongBuy and IRIX is a Hold.
DRIO's RSI Indicator is staying in oversold zone for 4 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where DRIO advanced for three days, in 177 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
DRIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DRIO as a result. In 83 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for DRIO turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 42 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
DRIO moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DRIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for DRIO entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.615) is normal, around the industry mean (3.981). P/E Ratio (-0.233) is within average values for comparable stocks, (13.628). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (2.386) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. DRIO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DRIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
IRIX sees MACD Histogram just turned negative
IRIX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 21, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 39 instances where the indicator turned negative. In 35 of the 39 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for IRIX moved out of overbought territory on October 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IRIX as a result. In 85 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
IRIX broke above its upper Bollinger Band on October 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
IRIX moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IRIX crossed bullishly above the 50-day moving average on October 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.
Following a +32.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRIX advanced for three days, in 153 of 205 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 81 of 112 cases where IRIX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. IRIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-5.671) is normal, around the industry mean (2.874). P/E Ratio (-3.812) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (3.870) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.204) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IRIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
DRIO | IRIX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 51 | 97 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 46 Fair valued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 94 | 59 | |
P/E GROWTH RATING 1..100 | 9 | 23 | |
SEASONALITY SCORE 1..100 | n/a | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DRIO's Valuation (46) in the Medical Specialties industry is in the same range as IRIX (78). This means that DRIO’s stock grew similarly to IRIX’s over the last 12 months.
DRIO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as IRIX (100). This means that DRIO’s stock grew similarly to IRIX’s over the last 12 months.
DRIO's SMR Rating (98) in the Medical Specialties industry is in the same range as IRIX (100). This means that DRIO’s stock grew similarly to IRIX’s over the last 12 months.
IRIX's Price Growth Rating (59) in the Medical Specialties industry is somewhat better than the same rating for DRIO (94). This means that IRIX’s stock grew somewhat faster than DRIO’s over the last 12 months.
DRIO's P/E Growth Rating (9) in the Medical Specialties industry is in the same range as IRIX (23). This means that DRIO’s stock grew similarly to IRIX’s over the last 12 months.
| DRIO | IRIX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 88% | 1 day ago 85% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 67% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 86% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 85% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 70% |
| Advances ODDS (%) | 16 days ago 75% | 15 days ago 75% |
| Declines ODDS (%) | 1 day ago 90% | 3 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 83% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 72% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DRIO’s FA Score shows that 1 FA rating(s) are green while IRIX’s FA Score has 1 green FA rating(s).
- DRIO’s FA Score: 1 green, 4 red.
- IRIX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DRIO’s TA Score shows that 4 TA indicator(s) are bullish while IRIX’s TA Score has 5 bullish TA indicator(s).
- DRIO’s TA Score: 4 bullish, 5 bearish.
- IRIX’s TA Score: 5 bullish, 5 bearish.
Price Growth
DRIO (@Services to the Health Industry) experienced а -32.48% price change this week, while IRIX (@Medical/Nursing Services) price change was -6.84% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.51%. For the same industry, the average monthly price growth was -3.63%, and the average quarterly price growth was +16.27%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
DRIO is expected to report earnings on Nov 12, 2026.
IRIX is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Services to the Health Industry (-1.51% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
DRIO and
Correlation & Price change
A.I.dvisor indicates that over the last year, DRIO has been loosely correlated with TWST. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if DRIO jumps, then TWST could also see price increases.
| Ticker / NAME | Correlation To DRIO | 1D Price Change % | ||
|---|---|---|---|---|
| DRIO | 100% | -5.98% | ||
| TWST - DRIO | 34% Loosely correlated | -9.16% | ||
| VCYT - DRIO | 28% Poorly correlated | -0.39% | ||
| XWEL - DRIO | 28% Poorly correlated | -2.45% | ||
| BNGO - DRIO | 28% Poorly correlated | -5.60% | ||
| ILMN - DRIO | 27% Poorly correlated | -4.76% | ||
More | ||||
IRIX and
Correlation & Price change
A.I.dvisor tells us that IRIX and NTRA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRIX and NTRA's prices will move in lockstep.
| Ticker / NAME | Correlation To IRIX | 1D Price Change % | ||
|---|---|---|---|---|
| IRIX | 100% | -0.70% | ||
| NTRA - IRIX | 30% Poorly correlated | -2.91% | ||
| NEO - IRIX | 27% Poorly correlated | -3.81% | ||
| IQV - IRIX | 27% Poorly correlated | +0.61% | ||
| MDXH - IRIX | 26% Poorly correlated | -14.34% | ||
| DRIO - IRIX | 26% Poorly correlated | -5.98% | ||
More | ||||